Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Bryan, Schneider"'
Autor:
Franck Carbonnel, Anusha Shirwaikar Thomas, Julie R Brahmer, John A Thompson, Yinghong Wang, Hao Chi Zhang, Bret Lashner, Michel Obeid, Stephen B Hanauer, Malek Shatila, Antonio Pizuorno Machado, Sidra Naz, Nitish Mittal, Christine Catinis, Krishnavathana Varatharajalu, Carolina Colli Cruz, Eric Lu, Deanna Wu, Bryan Schneider, David P Farris
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Gastrointestinal immune-related adverse events (GI irAEs) are common manifestations of immune checkpoint inhibitor (ICI) toxicity. We present a comprehensive systematic review of the incidence, management, and clinical course of irAEs across the enti
Externí odkaz:
https://doaj.org/article/f5eba1d7d1a949bcaf4019ce1376b9b5
Autor:
Kevin J. Chua, Shane Kronstedt, Alain Kaldany, Arnav Srivastava, Sai Krishnaraya Doppalapudi, Hao Liu, Ahmad A. Tarhini, Margaret Gatti‐Mays, Elizabeth Gaughan, Siwen Hu‐Lieskovan, Raid Aljumaily, Kenneth Nepple, Bryan Schneider, Joshua Sterling, Eric A. Singer
Publikováno v:
Cancer Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background Immuno‐oncology therapy (IO) is associated with a variety of treatment‐related toxicities. However, the impact of toxicity on the treatment discontinuation rate between males and females is unknown. We hypothesized that immune
Externí odkaz:
https://doaj.org/article/e33cef4ad0604f29894c47281a57ee1a
Autor:
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)
Abstract The excellent outcomes seen in patients treated with adjuvant trastuzumab emtansine (T-DM1) in the ATEMPT trial and the favorable toxicity profile associated with this agent make T-DM1 a potential therapeutic option for select patients with
Externí odkaz:
https://doaj.org/article/e88fcc1488804534afd42026e28dc869
Autor:
Hirva Mamdani, Bryan Schneider, Susan M. Perkins, Heather N. Burney, Pashtoon Murtaza Kasi, Laith I. Abushahin, Thomas Birdas, Kenneth Kesler, Tracy M. Watkins, Sunil S. Badve, Milan Radovich, Shadia I. Jalal
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundMost patients with resectable locally advanced esophageal and gastroesophageal junction (GEJ) adenocarcinoma (AC) receive concurrent chemoradiation (CRT) followed by esophagectomy. The majority of patients do not achieve pathologic complete
Externí odkaz:
https://doaj.org/article/f9a4664453e6418fabce1ca1942a0473
Autor:
Alexi Vasbinder, YeeAnn Chen, Adrien Procureur, Allison Gradone, Tariq U. Azam, Daniel Perry, Husam Shadid, Elizabeth Anderson, Tonimarie Catalan, Pennelope Blakely, Namratha Nelapudi, Mohamad Fardous, Marie C. Bretagne, Sarah K. Adie, Kristen T. Pogue, Monika Leja, Sarah Yentz, Bryan Schneider, Leslie A. Fecher, Christopher D. Lao, Joe-Elie Salem, Salim S. Hayek
Publikováno v:
JACC: CardioOncology. 4:689-700
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8a4bf51b33e5aeb3e02e41241502307
https://doi.org/10.1016/j.jaccao.2022.11.004
https://doi.org/10.1016/j.jaccao.2022.11.004
Autor:
Malek Shatila, Weijie Ma, Yantong Cui, Sidra Naz, Anusha S. Thomas, Enrico N. De Toni, Helga-Paula Török, Najib Ben Khaled, Mehmet Altan, Bryan Schneider, Yinghong Wang
Publikováno v:
Journal of Cancer Research and Clinical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::301d46053f5173caba5f20669c69084b
https://doi.org/10.1007/s00432-023-04736-9
https://doi.org/10.1007/s00432-023-04736-9
Autor:
Antoinette J. Wozniak, Bryan Schneider, Gregory P. Kalemkerian, Bobby Daly, Wei Chen, Jaclyn Ventimiglia, Misako Nagasaka, Marjorie G. Zauderer
Publikováno v:
Clinical Lung Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db40387ce89dd35fd5770bbddbd16a1e
https://doi.org/10.1016/j.cllc.2023.04.004
https://doi.org/10.1016/j.cllc.2023.04.004
Autor:
Shanu Modi, Clifford Hudis, Weining Ma, Ziyang Zhong, Alison Hannah, Linnea Chap, Bryan Schneider, Lee Rosen, Kathy Miller, Komal Jhaveri
PDF file, 37K, Human PBMCs Sample Preparation, Western Blot assay for Hsp90 Client Proteins, Luminex Assay for Hsp90 Client Proteins.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e7c5ed059556ba56e89efc1ff80b85
https://doi.org/10.1158/1078-0432.22446650
https://doi.org/10.1158/1078-0432.22446650
Autor:
Shanu Modi, Clifford Hudis, Weining Ma, Ziyang Zhong, Alison Hannah, Linnea Chap, Bryan Schneider, Lee Rosen, Kathy Miller, Komal Jhaveri
Purpose: We conducted a phase I dose-escalation study to define the maximum tolerated dose (MTD), pharmacokinetics (PK), and pharmacodynamics of alvespimycin (17-DMAG), a heat shock protein 90 (Hsp90) inhibitor, given in combination with trastuzumab.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495c890b6434076fc53476a03c552a3f
https://doi.org/10.1158/1078-0432.c.6520811
https://doi.org/10.1158/1078-0432.c.6520811
Autor:
Maryam Lustberg, Xuan Wu, Juan Luis Fernández-Martínez, Enrique J. de Andrés-Galiana, Santosh Philips, Jeffrey Leibowitz, Bryan Schneider, Stephen Sonis
Publikováno v:
Supportive Care in Cancer. 31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec6d5c5b0c9ee5f27c447a34dcb5ffe5
https://doi.org/10.1007/s00520-023-07617-6
https://doi.org/10.1007/s00520-023-07617-6